VERCYTE Drug Patent Profile
✉ Email this page to a colleague
When do Vercyte patents expire, and what generic alternatives are available?
Vercyte is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in VERCYTE is pipobroman. Additional details are available on the pipobroman profile page.
Summary for VERCYTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,812 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VERCYTE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VERCYTE
US Patents and Regulatory Information for VERCYTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |